Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer.

Skwarski M. et al, (2021), Clin Cancer Res

A Prospective Study of Diffusion-weighted Magnetic Resonance Imaging as an Early Prognostic Biomarker in Chemoradiotherapy in Squamous Cell Carcinomas of the Anus.

Muirhead R. et al, (2020), Clin Oncol (R Coll Radiol), 32, 874 - 883

Repurposing Atovaquone as a Tumor Hypoxia Modifier: A Window of Opportunity Study in Patients with Resectable Non-small Cell Lung Cancer

Skwarski M. et al, (2020), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108, S173 - S173

Symptom burden and unmet needs in MPM: exploratory analyses from the RESPECT-Meso study

Nge Hoon S. et al, (2020), Journal of Palliative Care

Exploring the use of Bayesian Techniques in a Surgical Trauma Randomised Control Trial

OOMS A. et al, (2020)

A prospective study of diffusion-weighted magnetic resonance imaging for predicting outcome following chemoradiotherapy, in squamous cell carcinomas of the anus

Muirhead R. et al, (2019)

Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial.

Brims F. et al, (2019), Thorax, 74, 354 - 361

The Relationship of Quality of Life, Physical Symptoms and Survival in Mesothelioma - Exploratory Analyses from the Respect-Meso Study

Brims F. et al, (2019), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 199

A randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma - 'RESPECT-Meso'

Brims F. et al, (2018), BRITISH JOURNAL OF CANCER, 119, 10 - 11

A phase I first-in-human, dose-escalation and expansion study to evaluate the safety and tolerability of NUC-3373 in patients with locally advanced, unresectable or metastatic solid malignancies

Blagden S. et al, (2018), ANNALS OF ONCOLOGY, 29

Nutritional intervention and neurodevelopmental outcome in infants with suspected cerebral palsy: the Dolphin infant double-blind randomized controlled trial.

Andrew MJ. et al, (2018), Dev Med Child Neurol, 60, 906 - 913

Corrigendum to "Heterologous Two-dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-lasting Cellular Immunity to Influenza Virus A in Healthy Adults" [EBioMedicine 29 (2018) 146-154].

Coughlan L. et al, (2018), EBioMedicine, 31

Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults.

Coughlan L. et al, (2018), EBioMedicine, 29, 146 - 154

IntReALL SR 2010: An international randomised phase III study for the treatment of standard risk childhood relapsed acute lymphoblastic leukaemia

von Stackelberg A. et al, (2017)

Include forthcoming?